Skip to search.
 TSX Up 0.21% TSX Ventures Down 1.58%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
2.10 Down 0.03(1.41%) 4:00PM EDT
Add to Portfolio
Prev Close:2.13
Open:2.07
Bid:2.05 x 500
Ask:2.95 x 300
1y Target Est:6.33
Beta:0.88
Next Earnings Date:N/A
Day's Range:2.06 - 2.14
52wk Range:2.02 - 9.30
Volume:92,972
Avg Vol (3m):152,957
Market Cap:77.46M
P/E (ttm):N/A
EPS (ttm):-1.17
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTHIDown 1.41%77.46M
GSKDown 0.33%100.97B
MRKUp 0.76%163.83B
PFEUp 1.44%207.70B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-1.32
Quarterly EPS Est (Jun-15) :-0.24
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback